Millions of people are turning to weight loss drugs like semaglutide and tirzepatide without medical supervision, relying on unreliable social media information instead of consulting healthcare providers. A recent survey of 613 Lebanese residents found that while most people recognize the need for medical oversight, the majority lack basic knowledge about how these medications work and their potential side effects. The findings highlight a growing public health crisis in developing countries where prescription medications are easily accessible without a doctor's approval .

What Do People Actually Know About Weight Loss Drugs?

The research painted a concerning picture of public understanding. Participants demonstrated limited knowledge about antidiabetic drugs used for weight loss, scoring an average of just 1.79 out of a possible scale, indicating significant gaps in comprehension . Despite this knowledge deficit, respondents showed they understood the importance of medical supervision. Nearly two-thirds of survey participants agreed that there is insufficient oversight in their country regarding how these medications are dispensed for weight loss purposes, and they emphasized the necessity for medical supervision when using these drugs .

The disconnect between what people know and what they're doing is striking. About 11.7% of respondents reported actually using medication for weight loss purposes, and the majority of those users experienced weight gain after stopping the medication . This pattern suggests that people are using these drugs without understanding how to maintain results or manage their health long-term.

Why Is Easy Access to Prescription Medications Dangerous?

In developing countries like Lebanon, medications are often available without a prescription, making it easier for people to self-medicate without professional guidance. This accessibility problem creates a perfect storm: people with limited knowledge about how these drugs work can easily obtain them, often influenced by social media trends rather than medical evidence. The study specifically noted that individuals are turning to self-medication with weight loss drugs, including antidiabetics, without seeking medical advice and often relying on unreliable information from social media platforms .

The risks of this approach extend beyond simple ineffectiveness. Weight loss medications like semaglutide, tirzepatide, and liraglutide work by triggering the pancreas to release insulin and delaying gastric emptying, which can help lower blood sugar levels and reduce appetite . Without proper medical monitoring, users may not understand how these mechanisms affect their individual health conditions, potential drug interactions, or whether they're candidates for these medications in the first place.

How to Ensure Safe Use of Weight Loss Medications

• Seek Medical Evaluation First: Before starting any weight loss medication, consult with a healthcare provider who can assess your medical history, current medications, and whether you're a suitable candidate for these drugs.
• Understand Your Specific Medication: Learn how your particular medication works, including its mechanism of action, expected timeline for results, and what happens when you stop taking it.
• Monitor for Side Effects: Work with your doctor to identify potential side effects specific to your health profile and establish a plan for managing them if they occur.
• Plan for Long-Term Management: Understand that weight loss medications are tools, not permanent solutions; discuss with your provider how to maintain results through lifestyle changes and ongoing medical supervision.
• Verify Information Sources: Rely on medical professionals and evidence-based health organizations rather than social media influencers or unverified online sources when making decisions about weight loss treatments.

The research underscores a critical need for public health interventions. The study authors emphasized that awareness campaigns and educational programs must focus on enhancing public knowledge regarding the use of drugs for weight loss and their possible side effects, especially off-label drugs that are being used outside their original FDA-approved purposes .

Interestingly, emerging research is exploring additional therapeutic uses for these medications beyond weight loss. Researchers at the University of Florida are currently investigating whether GLP-1 receptor agonists (the class of drugs that includes semaglutide and tirzepatide) might help treat certain types of endometrial cancer in patients who are not candidates for surgery . These developments highlight how important it is for patients to work with informed healthcare providers who understand the full scope of these medications' potential benefits and risks.

The bottom line is clear: while weight loss medications represent a significant advancement in obesity treatment, they require proper medical oversight. The gap between public knowledge and public access to these drugs is creating a health crisis that demands urgent attention from policymakers, healthcare systems, and public health organizations worldwide.